What Are Wall Street Targets for TELL, LGCY, AROC, and CLB?

Analysts’ recommendations

To conclude this series on the biggest movers in the upstream and oilfield services sectors, we’ll now look at Wall Street recommendations for the leading gainers and decliners this week that we have been discussing in this series.

What Are Wall Street Targets for TELL, LGCY, AROC, and CLB?

Recommendations for Tellurian

As of July 3, Reuters reported four analysts having recommendations on Tellurian (TELL). One has rated the stock a “strong buy,” two have rated the stock a “buy,” while one analyst has a “hold” recommendation on TELL. There aren’t any “sell” or “strong sell” ratings on the stock. The median price target for TELL is $14.00, which is ~10% higher than the July 3 closing price of $12.75.

Analysts’ target price potential for LGCY, AROC, and CLB

Based on the median price targets from Wall Street analysts, Legacy Reserves (LGCY), Archrock (AROC), and Core Laboratories (CLB) have potential upsides of ~29%, ~11%, and ~4%, respectively, from their July 3 closing prices.